Biotricity analyst ratings
Biotricity analyst ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/15/2022 | 48.15% | HC Wainwright & Co. | $6 → $2 | Maintains | Buy |
| 03/07/2022 | 270.37% | Lake Street | → $5 | Initiates Coverage On | → Buy |
| 11/23/2021 | 344.44% | HC Wainwright & Co. | → $6 | Initiates Coverage On | → Buy |
| 07/01/2021 | 418.52% | Northland Capital Markets | → $7 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 07/15/2022 | 48.15% | HC Wainwright & Co. | 6 美元 → 2 美元 | 维护 | 买 |
| 03/07/2022 | 270.37% | 湖街 | → 5 美元 | 启动覆盖范围开启 | → 购买 |
| 11/23/2021 | 344.44% | HC Wainwright & Co. | → 6 美元 | 启动覆盖范围开启 | → 购买 |
| 07/01/2021 | 418.52% | 北国资本市场 | → 7 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
Biotricity Questions & Answers
生物学问题与解答
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on July 15, 2022. The analyst firm set a price target for $2.00 expecting BTCY to rise to within 12 months (a possible 48.15% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2022年7月15日公布了Biotricity（纳斯达克股票代码：BTCY）的最新目标股价。该分析公司将目标股价定为2.00美元，预计BTCY将在12个月内升至12个月内（可能上涨48.15％）。去年有3家分析公司公布了评级。
The latest analyst rating for Biotricity (NASDAQ: BTCY) was provided by HC Wainwright & Co., and Biotricity maintained their buy rating.
HC Wainwright & Co. 对Biotricity（纳斯达克股票代码：BTCY）的最新分析师评级由HC Wainwright & Co. 提供，Biotricity维持买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biotricity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biotricity was filed on July 15, 2022 so you should expect the next rating to be made available sometime around July 15, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Biotricity的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Biotricity的最新评级是在2022年7月15日发布的，因此您应该预计下一个评级将在2023年7月15日左右公布。
While ratings are subjective and will change, the latest Biotricity (BTCY) rating was a maintained with a price target of $6.00 to $2.00. The current price Biotricity (BTCY) is trading at is $1.35, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Biotricity（BTCY）评级维持不变，目标股价为6.00美元至2.00美元。Biotricity（BTCY）目前的交易价格为1.35美元，超出了分析师的预期区间。